C
BIO icon

Covestor’s Bio-Rad Laboratories Class A BIO Stock Holding History

Covestor’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84K Buy
287
+269
+1,494% +$76.3K 0.05% 460
2026
Q1 		$5K Sell
18
-52
-74% -$15K ﹤0.01% 1779
2025
Q4 		$21K Buy
70
+38
+119% +$11.9K 0.01% 1261
2025
Q3 		$9K Sell
32
-58
-64% -$15.8K 0.01% 1636
2025
Q2 		$22K Buy
90
+48
+114% +$11.3K 0.01% 1215
2025
Q1 		$10K Sell
42
-14
-25% -$4.21K 0.01% 1474
2024
Q4 		$19K Sell
56
-75
-57% -$25.5K 0.01% 1206
2024
Q3 		$44K Buy
131
+22
+20% +$6.99K 0.03% 922
2024
Q2 		$30K Buy
109
+45
+70% +$13.1K 0.02% 1048
2024
Q1 		$22K Buy
64
+48
+300% +$15.8K 0.01% 1180
2023
Q4 		$5K Hold
16
– – ﹤0.01% 1762
2023
Q3 		$6K Sell
16
-1
-6% -$386 ﹤0.01% 1662
2023
Q2 		$7K Sell
17
-155
-90% -$63.1K 0.01% 1624
2023
Q1 		$83K Sell
172
-33
-16% -$15.4K 0.07% 479
2022
Q4 		$87K Buy
205
+1
+0.5% +$404 0.07% 464
2022
Q3 		$85K Buy
204
+9
+5% +$4.49K 0.07% 435
2022
Q2 		$97K Buy
195
+26
+15% +$13.5K 0.08% 435
2022
Q1 		$95K Buy
169
+92
+119% +$55.5K 0.06% 534
2021
Q4 		$59K Buy
+77
New +$57.6K 0.08% 435

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Covestor's BIO Position: Q2 2026 in Review

Covestor increased its Bio-Rad Laboratories Class A (BIO) stake by 1,494% in Q2 2026, buying an estimated $76.3K and bringing the position to 287 shares worth $84K. The position accounts for 0.05% of the portfolio, ranked #460.

Covestor first reported a position in BIO in Q4 2021 and has held it in 19 quarters since. The position peaked at $97K in Q2 2022. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Covestor held 287 shares of Bio-Rad Laboratories Class A worth $84K as of Q2 2026.
  • Covestor bought 269 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $76.3K.
  • Bio-Rad Laboratories Class A made up 0.05% of Covestor's portfolio in Q2 2026, its #460 holding.
  • Covestor first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Bio-Rad Laboratories Class A position peaked at $97K in Q2 2022.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.